Beyond traditional benefit plan services and insurance, we deliver proprietary tools and specialized resources designed to support your unique needs. We have dedicated specialists in each of the areas below and our long-standing market relationships allow us to innovate on behalf of clients rather than settle for a one-size-fits-all approach.
The combined expertise of our preeminent employee benefits, business insurance, risk management, retirement planning and specialist resource teams form a coordinated consultative process that delivers superior results for you.
One of the compliance obligations that comes with offering employee benefits is the requirement to offer certain participants in certain plans the opportunity to continue coverage for some period of time in certain circumstances when coverage would otherwise have been lost. But which employers have to offer continuation? On which plans? When? To whom? For how long? The answers to these questions depend on several factors.
In addition to COVID-19’s deadly impact on our population, it has also hit many businesses hard. Not only have there been customer declines and governmental shut-down orders, but employers have had to manage through a myriad of COVID-related employee absences. Fortunately, hope may be on the horizon, as the U.S. Federal Drug Administration (FDA) is approving vaccines for wide distribution. However, with hope comes challenge, as businesses now need to decide whether and how they will make employee vaccinations part of their COVID response planning.
USI’s Executive and Professional Risk Solutions (EPS) Practice is dedicated to helping clients stay abreast of important regulatory developments and court decisions that may impact management liability exposures. The USI EPS team has released two recent client advisories addressing the directors and officers (D&O) policy implications from COVID-19 vaccine mandates and board diversity.
Send a Message
Find a Location